Transforming activity of DNA from rat liver tumors induced by the carcinogen methyl(acetoxymethyl)nitrosamine

M Goyette1, M Dolan, W Kaufmann

  • 1Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.

Molecular Carcinogenesis
|January 1, 1988
PubMed

Insights

Ras gene mutations are infrequent in rat liver cancer induced by methyl(acetoxymethyl)nitrosamine. Instead, other activated genes, not homologous to common oncogenes, drive tumor development and NIH 3T3 cell transformation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatocarcinogenesis

Background:

  • Altered c-Ha-ras genes are common in mouse liver tumors.
  • Ras gene mutations are suspected drivers of carcinogenesis.

Purpose of the Study:

  • To investigate ras gene mutation frequency during rat liver carcinogenesis.
  • To identify activated oncogenes in methyl(acetoxymethyl)nitrosamine-induced rat liver tumors.

Main Methods:

  • Induction of rat liver tumors using methyl(acetoxymethyl)nitrosamine and phenobarbital.
  • DNA extraction from tumors and NIH 3T3 cell transfection assays.
  • Southern blot analysis to identify transforming genes in transfectants.

Main Results:

  • Six of eight tumor DNAs induced NIH 3T3 cell transformation.
  • Transforming activity was stable and tumorigenic in nude mice.
  • Ras gene family members (Ha, Ki, N), neu, myc, A-raf, v-raf, erbA, or erbB were not responsible for transformation.

Conclusions:

  • Ras gene alterations are infrequent in this rat hepatocarcinogenesis model.
  • Novel, non-ras oncogenes are activated during DMN-OAc-induced liver cancer.
  • These activated genes are capable of NIH 3T3 cell transformation.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).